$3.92

+0.07 (+1.82%)

Weekly Expected Move ±12.2%

$3 $3 $4 $4 $4

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Sell · Power 40 · $645.3M mcap · 158M float · 1.79% daily turnover · Short 52% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$296M -15.7% ▼

5Y CAGR: -5.3%

Gross Profit

$294M -14.4% ▼

5Y CAGR: -5.3%

Operating Income

$119M +27.5% ▲

5Y CAGR: -3.6%

Net Income

$24M +2629.2% ▲

5Y CAGR: -25.7%

EPS (Diluted)

$0.15 +2627.3% ▲

5Y CAGR: -25.6%

EBITDA

$105M +7.1% ▲

5Y CAGR: -5.9%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$414M	$411M	$443M	$351M	$296M
YoY Growth	+6.2%	-0.8%	+7.8%	-20.6%	-15.7%
Cost of Revenue	$70M	$1M	$6M	$8M	$2M
Gross Profit	$343M	$409M	$437M	$344M	$294M
Gross Margin	83.0%	99.7%	98.6%	97.9%	99.4%
R&D Expenses	$70M	$44M	$116M	$111M	$95M
SG&A Expenses	$0	$116M	$0	$0	$82M
Operating Expenses	$111M	$159M	$1.4B	$251M	$176M
Operating Income	$232M	$250M	-$945M	$93M	$119M
Operating Margin	56.1%	61.0%	-213.5%	26.5%	40.1%
Interest Expense	$31M	$8M	$22M	$33M	$33M
Income Before Tax	$201M	$252M	-$948M	$65M	$70M
Tax Expense	-$328M	$77M	$83M	$64M	$46M
Net Income	$528M	$175M	-$1.0B	$880K	$24M
Net Margin	127.7%	42.6%	-226.4%	0.3%	8.1%
EPS (Diluted)	$3.21	$0.96	$-6.45	$0.01	$0.15
EBITDA	$234M	$261M	$197M	$98M	$105M
Shares Outstanding	164M	186M	155M	160M	178M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$94M	$92M	$91M	$41M	$85M	$122M	$48M	$107M
Cost of Revenue	$0	$30M	$0	$27M	$0	$0	$0	$443K
Gross Profit	$94M	$62M	$91M	$14M	$85M	$122M	$48M	$106M
Gross Margin	100.0%	67.4%	100.0%	33.3%	100.0%	100.0%	100.0%	99.6%
R&D Expenses	$30M	$30M	$25M	$27M	$23M	$22M	$22M	$21M
SG&A Expenses	$37M	$36M	$34M	$0	$17M	$22M	$19M	$12M
Operating Expenses	$69M	$36M	$59M	$43M	$40M	$47M	$41M	$34M
Operating Income	$25M	$26M	$31M	-$29M	$45M	$75M	$7M	$73M
Operating Margin	26.5%	28.0%	34.8%	-70.7%	53.2%	61.8%	13.7%	68.1%
Interest Expense	$7M	$9M	$9M	$8M	$8M	$8M	$8M	$9M
Income Before Tax	$19M	$17M	$24M	-$36M	$38M	$68M	$455K	$65M
Tax Expense	$20M	$14M	$22M	$1M	$14M	$28M	$3M	$24M
Net Income	-$860K	$4M	$2M	-$37M	$24M	$40M	-$2M	$41M
Net Margin	-0.9%	4.0%	2.5%	-90.9%	27.7%	32.8%	-4.8%	38.3%
EPS (Diluted)	$-0.01	$0.02	$0.01	$-0.23	$0.14	$0.23	$-0.01	$0.24
EBITDA	$27M	$27M	$33M	-$10M	$47M	$77M	$9M	$73M
Shares Outstanding	159M	160M	160M	161M	162M	178M	178M	167M

IRWD NASDAQ